D. Sleijfer

发表

The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours.

H. Groen, H. Hollema, J. Bart, 2004, European journal of cancer.

Association of PAI‐1 gene polymorphism with survival and chemotherapy‐related vascular toxicity in testicular cancer

H. Boezen, H. Hoekstra, H. Guchelaar, 2010, Cancer.

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.

S. Fosså, D. Dearnaley, A. Horwich, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The relation between soluble apoptotic proteins and subclinical cardiotoxicity in adjuvant-treated breast cancer patients.

E. D. de Vries, J. Gietema, W. T. van der Graaf, 2006, Anticancer research.

Evaluation of gastrointestinal toxicity following cytostatic chemotherapy

N. Mulder, D. Sleijfer, J. Smit, 2004, Journal of Cancer Research and Clinical Oncology.

Gastrointestinal toxicity of chemotherapy and the influence of hyperalimentation

J. Koudstaal, N. Mulder, D. Sleijfer, 1986, Cancer.

Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.

R. Sylvester, A. V. van Oosterom, S. Kaye, 1987, Cancer research.

Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. European Organization for Research and Treatment of Cancer.

L. Collette, R. Sylvester, R. de Wit, 1998, British Journal of Cancer.

Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer.

N. Mulder, E. de Vries, P. Willemse, 1997, British Journal of Cancer.

Karyotyping and DNA flow cytometry of mature residual teratoma after intensive chemotherapy of disseminated nonseminomatous germ cell tumor of the testis: a report of two cases.

C. Cornelisse, D. Sleijfer, I. Molenaar, 1986, Cancer genetics and cytogenetics.

The effect of amphotericin B lozenges on the presence and number of candida cells in the oropharynx of neutropenic leukemia patients

D. Sleijfer, N. Mulder, H. V. Saene, 2005, Infection.

Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance.

D. Sleijfer, C. Cornelisse, J. Oosterhuis, 1989, Laboratory investigation; a journal of technical methods and pathology.

Ploidy of testicular carcinoma in situ.

W. van Putten, D. Sleijfer, J. Oosterhuis, 1992, Laboratory investigation; a journal of technical methods and pathology.

The surface antigen phenotype of human embryonal carcinoma cells: modulation upon differentiation and viral infection.

P. Andrews, É. Gönczöl, D. Sleijfer, 1991, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors

E. D. de Vries, J. Gietema, W. T. van der Graaf, 2006, Acta oncologica.

Is chemotherapy associated with development of Barrett's esophagus?

J. Kleibeuker, D. Sleijfer, F. Peters, 1993, Digestive Diseases and Sciences.

Re-analysis of the Xq27-Xq28 region suggests a weak association of an X-linked gene with sporadic testicular germ cell tumour without cryptorchidism.

I. Nolte, H. Hoekstra, R. Sijmons, 2006, European journal of cancer.

Learning effects of a workshop in palliative cancer care for general practitioners.

R. Otter, D. Sleijfer, W. J. Meijler, 2009, Journal of cancer education : the official journal of the American Association for Cancer Education.

Management of Chemotherapy-Induced Adverse Effects in the Treatment of Colorectal Cancer

D. Sleijfer, J. Brouwers, F. Jansman, 2001, Drug safety.

Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.

A. V. D. Van Der Zee, N. Mulder, E. de Vries, 1995, European journal of cancer.

A phase I-II study of 14-days continuous infusion of 5-fluorouracil with weekly bolus leucovorin in metastatic colorectal carcinoma.

N. Mulder, D. Sleijfer, R. Verschueren, 1992, European journal of cancer.

Modification of 5-fluorouracil activity by high-dose methotrexate or leucovorin in advanced colorectal carcinoma.

N. Mulder, E. de Vries, D. Sleijfer, 1990, European journal of cancer.

Self-esteem, social support, and mental health in survivors of testicular cancer: a comparison based on relationship status.

H. Hoekstra, M. Tuinman, J. Hoekstra-Weebers, 2006, Urologic oncology.

Clinical and therapeutic aspects of extrapulmonary small cell carcinoma.

G. Sonke, D. Sleijfer, A. Walenkamp, 2009, Cancer treatment reviews.

Phase II study of carboplatin and cytosine arabinoside in patients with disseminated malignant melanoma

D. Sleijfer, E. Vries, N. Mulder, 2005, Journal of Cancer Research and Clinical Oncology.

Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma

D. Sleijfer, E. Vries, N. Mulder, 2004, Journal of Cancer Research and Clinical Oncology.

Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study

D. Sleijfer, H. Groen, J. Smeets, 2000, British Journal of Cancer.

Phase I–II study of the addition of α-2a interferon to 5-fluorouracil/leucovorin. Pharmacokinetic interaction of α-2a interferon and leucovorin

N. Mulder, J. Buter, D. Sleijfer, 1993 .

A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin.

N. Mulder, E. de Vries, D. Sleijfer, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

High-dose cyclophosphamide and high-dose VP 16-213 for recurrent or refractory small cell lung cancer. A phase II study.

E. de Vries, D. Sleijfer, N. Mulder, 1985, European journal of cancer & clinical oncology.

Changes in pulmonary function during and after bleomycin treatment in patients with testicular carcinoma

N. Mulder, D. Sleijfer, H. Koops, 2004, Cancer Chemotherapy and Pharmacology.

Phase II and pharmacokinetic study of lobaplatin in patients with relapsed ovarian cancer.

A. Cats, E. D. de Vries, E. de Vries, 1995, British Journal of Cancer.

A phase I-II study with intraperitoneal cisplatin plus systemic etoposide in patients with minimal residual ovarian cancer.

E. D. de Vries, N. Mulder, J. Bouma, 1992, European journal of cancer.

Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.

H. Boezen, H. Hoekstra, N. Zwart, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors

W. Molenaar, H. Hoekstra, D. Sleijfer, 1998 .

Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin‐vinblastine‐bleomycin chemotherapy

D. Sleijfer, N. Mulder, J. Oosterhuis, 1988, Journal of surgical oncology.

The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.

A. Smit, B. Wolffenbuttel, H. Hoekstra, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dacarbazine (DTIC), human recombinant interferon alpha 2a (Roferon) and 5-fluorouracil for disseminated malignant melanoma.

N. Mulder, E. de Vries, D. Sleijfer, 1992, British Journal of Cancer.

Dose escalation of dacarbazine combined with interferon alpha-2a, G-CSF and ondansetron in patients with metastatic melanoma.

N. Mulder, E. de Vries, W. T. van der Graaf, 1994, Anticancer research.

No recurrent structural abnormalities apart from i(12p) in primary germ cell tumors of the adult testis

L. Looijenga, D. Sleijfer, J. Oosterhuis, 1995, Genes, chromosomes & cancer.

Syndromic aspects of testicular carcinoma

H. Hoekstra, J. Hoekstra-Weebers, R. Sijmons, 2003, Cancer.

Tra‐1‐60: A new serum marker in patients with germ‐cell tumors

P. Andrews, D. Sleijfer, J. Oosterhuis, 1991, International journal of cancer.

Cytogenetics of primary testicular nonseminoma, residual mature teratoma, and growing teratoma lesion in individual patients.

D. Sleijfer, J. Oosterhuis, H. Koops, 1997, Cancer genetics and cytogenetics.

High-Dose Chemotherapy for Small Cell Lung Cancer

P. Postmus, N. Mulder, D. Sleijfer, 1986 .

Cyclophosphamide and VP 16-213 with autologous bone marrow transplantation. A dose escalation study.

E. de Vries, D. Sleijfer, N. Mulder, 1984, European journal of cancer & clinical oncology.

Marital and sexual satisfaction in testicular cancer survivors and their spouses

H. Hoekstra, M. Tuinman, J. Hoekstra-Weebers, 2005, Supportive Care in Cancer.

Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.

P. Postmus, N. Mulder, E. de Vries, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer.

A. Smit, A. V. van Roon, M. P. van den Berg, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mediastinal germ cell tumor with secondary nongerm cell malignancy, and extensive hematopoietic activity. Pathology, DNA-ploidy, and karyotyping.

E. van den Berg, W. Timens, D. Sleijfer, 1991, Cancer genetics and cytogenetics.

Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment

D. Breimer, D. Sleijfer, P. Willemse, 2004, Cancer Chemotherapy and Pharmacology.

83 6 SERUM HER 2 LEVELS ARE INCREASED IN PATIENTS WITH CHRONIC HEART FAILURE

D. J. Veldhuisen, J. Gietema, D. Sleijfer, 2005 .

Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer.

N. Mulder, J. Bouma, D. Sleijfer, 1984, Gynecologic oncology.

5 111 IN-LABELED TRASTUZUMAB SCINTIGRAPHY IN PATIENTS WITH HER 2-POSITIVE METASTATIC BREAST CANCER

D. J. Veldhuisen, J. Kosterink, J. Gietema, 2005 .

Patient motivation and informed consent in a phase I study of an anticancer agent.

S. Rodenhuis, N. Mulder, D. Sleijfer, 1984, European journal of cancer & clinical oncology.

The tumor microenvironment: possible role of integrins and the extracellular matrix in tumor biological behavior of intratubular germ cell neoplasia and testicular seminomas.

W. Timens, D. Sleijfer, B. G. Szabó, 1994, The American journal of pathology.

Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy

H. Hoekstra, D. Vidrine, M. Tuinman, 2006, Supportive Care in Cancer.

The effect of continuous enteral tube feeding on various nutritional parameters in patients with disseminated malignant melanoma during intensive chemotherapy.

D. Sleijfer, N. Mulder, H. Schraffordt koops, 1983, Clinical nutrition.

Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.

N. Mulder, E. de Vries, W. T. van der Graaf, 1999, The Journal of antimicrobial chemotherapy.

Acute effects of cis-diamminedichloroplatinum (CDDP) on renal function

A. Donker, N. Mulder, D. Sleijfer, 2004, Cancer Chemotherapy and Pharmacology.

Non-seminomatous germ cell tumors of the testis: morphology of retroperitoneal lymph node metastases after chemotherapy.

D. Sleijfer, A. Suurmeijer, J. Oosterhuis, 1984, European journal of cancer & clinical oncology.

Sarcoid reaction mimicking intrathoracic dissemination of testicular cancer

P. Postmus, H. Hoekstra, J. Oosterhuis, 1990, Cancer.

Adsorptive Voltametry to Determine Platinum Levels in Plasma From Testicular Cancer Patients Treated With Cisplatin

D. Sleijfer, D. Uges, J. Franke, 2001, Therapeutic drug monitoring.

Weakness and numbness after chemotherapy for metastatic non-seminoma testis: A new neurological complication

J. Gietema, D. Sleijfer, R. Verdonk, 2008, Acta oncologica.

Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer.

H. Groen, N. Mulder, E. de Vries, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neo-adjuvant chemotherapy with carboplatin, 4-epiadriamycin and teniposide (CET) in locally advanced cancer of the cardia and the lower oesophagus: a phase II study.

N. Mulder, W. T. van der Graaf, D. Sleijfer, 1995, Anticancer research.

Small cell lung cancer in the elderly. Factors influencing the results of chemotherapy: a review

E. Smit, P. Postmus, D. Sleijfer, 1989 .

Risks and benefits of cisplatin in ovarian cancer. A quality-adjusted survival analysis.

N. Mulder, E. de Vries, J. Bouma, 1990, European Journal of Cancer.

Intraperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancer.

N. Mulder, E. de Vries, J. Bouma, 1990, European journal of cancer.

Chemotherapy for central nervous system metastases from small cell lung cancer. A review

P. Postmus, D. Sleijfer, H. Haaxma-Reiche, 1989 .

High-dose etoposide for central nervous system metastases of small cell lung cancer. Preliminary results.

P. Postmus, G. T. ten Velde, D. Sleijfer, 1987, European journal of respiratory diseases. Supplement.

Outpatient-based subcutaneous interleukin-2 monotherapy in advanced renal cell carcinoma: an update.

L. de Leij, J. Buter, D. Sleijfer, 1996, Cancer biotherapy & radiopharmaceuticals.

Infection after subcutaneous interleukin-2

J. Buter, D. Sleijfer, E. Vries, 1992, The Lancet.

Cisplatin-based chemotherapy changes the incidence of bilateral testicular cancer

H. Hoekstra, D. Sleijfer, J. Droste, 1997, Annals of Surgical Oncology.

Effects of recombinant human interleukin-6 with or without recombinant human granulocyte-macrophage colony-stimulating factor before and after chemotherapy

H. Groen, N. Mulder, E. Vries, 1997 .

High-dose teniposide for refractory malignancies: a phase I study.

N. Mulder, E. de Vries, D. Sleijfer, 1986, Cancer treatment reports.

Serum Alpha-Fetoprotein Surge After the Initiation of Chemotherapy for Non-Seminomatous Testicular Cancer Has an Adverse Prognostic Significance

L. Collette, A. Oosterom, R. Sylvester, 1999 .

Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.

L. Collette, R. Sylvester, S. Kaye, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral etoposide for a 95-year-old patient with small cell lung cancer.

E. Smit, P. Postmus, D. Sleijfer, 1989, Chest.

Some effects of combination chemotherapy with cis‐platinum on renal function in patients with nonseminomatous testicular carcinoma

N. Mulder, D. Sleijfer, W. Sluiter, 1983, Cancer.

Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin beta-subunit and pituitary gonadal hormones.

H. Hoekstra, J. Gietema, R. Dullaart, 2009, Fertility and sterility.

Gonadal function after surgery and chemotherapy in men with stage II and III nonseminomatous testicular tumors.

J. Kremer, D. Sleijfer, H. Koops, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Fertility and hormonal function in patients with a nonseminomatous tumor of the testis.

D. Sleijfer, P. Willemse, H. Schraffordt koops, 1985, Archives of andrology.

Acute nonlymphocytic leukemia 5 years after treatment with cisplatin, vinblastine, and bleomycin for disseminated testicular cancer

M. R. Halie, N. Mulder, M. Breuning, 1986, Cancer.

Renal dysfunction following high-dose carboplatin treatment

N. Mulder, D. Sleijfer, E. Vries, 2004, Journal of Cancer Research and Clinical Oncology.

Acute and cumulative effects of carboplatin on renal function.

E. Smit, P. Postmus, D. Sleijfer, 1989, British Journal of Cancer.

Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.

E. Vellenga, N. Mulder, E. de Vries, 1992, Blood.

Effects of interleukin-3 after chemotherapy for advanced ovarian cancer

de Elisabeth G. E. Vries, E. Vellenga, N. Mulder, 1992 .

Late recurrence of mature teratoma in nonseminomatous testicular tumors after PVB chemotherapy and surgery.

D. Sleijfer, J. Oosterhuis, H. Koops, 1989, Urology.

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group.

R. Sylvester, S. Kaye, P. D. De Mulder, 1995, British Journal of Cancer.

Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience.

H. D. de Bruijn, D. Sleijfer, N. Freling, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Surgery versus surveillance in stage I non-seminoma testicular cancer.

D. Sleijfer, H. Koops, H. J. Hoekstra, 1999, Seminars in surgical oncology.

Sexual function, depressive symptoms and marital status in nonseminoma testicular cancer patients: a longitudinal study

H. Hoekstra, D. Vidrine, M. Tuinman, 2010, Psycho-oncology.

D. Dearnaley, A. Horwich, R. Sylvester, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized comparison of megestrol acetate (MA) and medroxyprogesterone acetate (MPA) in patients with advanced breast cancer.

D. Sleijfer, E. van der Ploeg, P. Willemse, 1990, European journal of cancer.

Sexual function after surgery and combination chemotherapy in men with disseminated nonseminomatous testicular cancer

D. Sleijfer, H. Koops, J. Oldhoff, 1988, Journal of surgical oncology.

Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damage.

E. de Vries, D. Sleijfer, H. Schraffordt koops, 1990, European journal of cancer.

Oral high‐dose medroxyprogesterone acetate versus tamoxifen: A randomized crossover trial in postmenopausal patients with advanced breast cancer

D. Sleijfer, P. Willemse, T. Tjabbes, 1986, Cancer.

CA-125 in ovarian cancer: relation between half-life, doubling time and survival.

N. Mulder, E. de Vries, D. Sleijfer, 1991, European journal of cancer.

A young female with an endodermal sinus tumor in a pericardial localized cyst.

W. T. van der Graaf, D. Sleijfer, T. S. van der Werf, 2000, Acta oncologica.

Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach.

W. Molenaar, H. Hoekstra, D. Sleijfer, 1998, Cancer.

Significance of aneuploid stemlines in testicular nonseminomatous germ cell tumors

D. Sleijfer, J. Oosterhuis, H. Koops, 1993, Cancer.

Long-term survival after vinblastine, bleomycin, and cisplatin treatment in patients with germ cell tumors of the ovary: An update

J. Bouma, E. Vries, D. Sleijfer, 1987 .

Absence of constitutional Y chromosome AZF deletions in patients with testicular germ cell tumors.

R. Sijmons, D. Sleijfer, K. Storm, 2005, Urology.

A phase II study of a 21 day continuous infusion schedule with epirubicin in advanced gastric cancer.

N. Mulder, E. de Vries, D. Sleijfer, 1989, European journal of cancer & clinical oncology.

Objective and subjective predictors of cancer-related stress symptoms in testicular cancer survivors.

H. Hoekstra, M. Tuinman, J. Hoekstra-Weebers, 2006, Patient education and counseling.

Protein composition of cyst fluids from mature teratoma in patients with nonseminomatous germ cell tumors of the testis

G. Fleuren, H. D. de Bruijn, T. Ockhuizen, 1985, Cancer.

EXCRETION OF PLATINUM INTO BREAST MILK

D. Sleijfer, E. Vries, D. Uges, 1989, The Lancet.

Serum ferritin determinations are of no value in the management of patients with disseminated non-seminomatous germ cell tumors.

H. D. de Bruijn, T. Ockhuizen, D. Sleijfer, 1985, European journal of cancer & clinical oncology.

Non–Germ Cell Malignancy in Residual or Recurrent Mass After Chemotherapy for Nonseminomatous Testicular Germ Cell Tumor

H. Hoekstra, N. Mulder, J. Gietema, 2003, Annals of surgical oncology.

Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significance.

L. Collette, R. Sylvester, A. V. van Oosterom, 1998, British Journal of Cancer.

Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

E. D. de Vries, E. de Vries, J. Kosterink, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Definition of a new entity of malignant extragonadal germ cell tumors

D. Weghuis, R. Sinke, D. Sleijfer, 1995, Genes, chromosomes & cancer.

Geographic clustering of testicular cancer incidence in the northern part of The Netherlands

R. Sijmons, D. Sleijfer, M. Schaapveld, 1999, British Journal of Cancer.

HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients

N. Mulder, J. Buter, T. The, 2005, Cancer Immunology, Immunotherapy.

Loss of the Y-chromosome in the primary metastasis of a male sex cord stromal tumor: pathogenetic implications.

D. Sleijfer, H. Koops, H. Schraffordt koops, 1999, Cancer genetics and cytogenetics.

Cytogenetic analysis of a mature teratoma and a yolk sac tumor component of a late relapse of a disseminated testicular nonseminoma.

D. Sleijfer, H. Schraffordt koops, B. de Jong, 1999, Cancer genetics and cytogenetics.

Comparison of the chromosomal pattern of primary testicular nonseminomas and residual mature teratomas after chemotherapy.

G. T. te Meerman, D. Sleijfer, J. Oosterhuis, 1997, Cancer genetics and cytogenetics.

Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancer.

E. Smit, J. Beijnen, D. Sleijfer, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Serum HER2 levels are increased in patients with chronic heart failure

D. J. Veldhuisen, J. Gietema, D. Sleijfer, 2007, European journal of heart failure.

Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer: a model update and multicentre validation with more than 1000 patients.

Yvonne Vergouwe, Ewout W Steyerberg, J. Habbema, 2007, European urology.

Recent developments in diagnosis and treatment of metastatic carcinoid tumours.

N. Mulder, E. de Vries, J. Kleibeuker, 1993, Scandinavian journal of gastroenterology. Supplement.

Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy.

J. Plukker, W. T. van der Graaf, D. Sleijfer, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.

H. D. de Bruijn, N. Mulder, E. de Vries, 1992, British Journal of Cancer.

Regional infusion of fluoropyrimidines for hepatic metastases of colorectal cancer

D. Sleijfer, J. Brouwers, C. Koks, 1988, Pharmaceutisch Weekblad.

Phase I/II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer.

L. de Leij, J. Buter, D. Sleijfer, 1993, European journal of cancer.

Effect of chemotherapy on taste sensation in patients with disseminated malignant melanoma.

D. Sleijfer, N. Mulder, H. Schraffordt koops, 1983, Oncology.

Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients

D. Sleijfer, N. Mulder, D. van der Waaij, 1981, Antimicrobial Agents and Chemotherapy.

Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer.

D. Sleijfer, P. Willemse, T. Tjabbes, 1986, Cancer.

Assessing the clinical significance of drug interactions with fluorouracil in patients with colorectal cancer.

W. M. Smit, D. Sleijfer, J. Brouwers, 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Ploidy of malignant mediastinal germ-cell tumors.

C. Cornelisse, D. Sleijfer, J. Oosterhuis, 1990, Human pathology.

Continuous infusion of chemotherapy on an outpatient basis via a totally implanted venous access port.

N. Mulder, E. de Vries, D. Sleijfer, 1991, European journal of cancer.

Chromosomal changes in mature residual teratomas following polychemotherapy.

G. T. te Meerman, R. Seruca, D. Sleijfer, 1989, Cancer research.

Palmar fasciitis and arthritis in a patient with an extraovarian adenocarcinoma of the coelomic epithelium.

N. Mulder, D. Sleijfer, P. Willemse, 1991, Annals of the rheumatic diseases.

Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors

D. Sleijfer, J. Oosterhuis, H. Koops, 1986, Cancer.

Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients

W. Sluiter, D. Sleijfer, P. Willemse, 1984, Cancer Chemotherapy and Pharmacology.

A phase II study of oral etoposide in elderly patients with small cell lung cancer.

E. Smit, P. Postmus, D. Carney, 1989, Thorax.

Treatment of brain metastases of small cell lung cancer with teniposide.

E. Smit, P. Postmus, D. Sleijfer, 1992, Seminars in oncology.

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.

H. Groen, P. Willemse, D. Sleijfer, 1999, British journal of cancer.

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

D. Sleijfer, N. Mulder, D. van der Waaij, 1980, European journal of cancer.

Children born after their fathers had been treated with chemotherapy for testicular cancer.

A. Mantingh, N. Mulder, E. de Vries, 1990, European Journal of Obstetrics, Gynecology, and Reproductive Biology.

Malignant struma ovarii treated by ovariectomy, thyroidectomy, and 131I administration

J. Oosterhuis, D. Sleijfer, D. Piers, 1987, Cancer.

Oral high-dose medroxyprogesterone acetate causes adrenal suppression in patients with breast cancer.

D. Sleijfer, P. Willemse, T. Tjabbes, 1982, European journal of cancer & clinical oncology.

Cisplatin: a review of clinical applications and renal toxicity

N. Mulder, D. Sleijfer, S. Meijer, 1985, Pharmaceutisch Weekblad.

Tumor markers in patients with non-seminomatous germ cell tumors of the testis.

H. D. de Bruijn, T. Ockhuizen, D. Sleijfer, 1981, Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Significance of human chorionic gonadotropin, alpha‐fetoprotein, and pregnancy‐specific beta‐1‐glycoprotein in the detection of tumor relapse and partial remission in 126 patients with nonseminomatous testicular germ cell tumors

H. D. de Bruijn, T. Ockhuizen, D. Sleijfer, 1985, Cancer.

Testicular germ cell tumors Gels

D. Sleijfer, N. Freling, J. Droste, 2017 .

Sexual Functioning After Treatment for Testicular Cancer—Review and Meta-Analysis of 36 Empirical Studies Between 1975–2000

Harald J. Hoekstra, H. V. D. van de Wiel, H. Hoekstra, 2001, Archives of sexual behavior.

Sexual functioning after treatment for testicular cancer

H. Hoekstra, H. Wiel, D. Sleijfer, 1997, Cancer.

Cytogenetic abnormalities and clinical stage in testicular nonseminomatous germ cell tumors.

G. T. te Meerman, D. Sleijfer, J. Oosterhuis, 1993, Cancer genetics and cytogenetics.

Chromosomal changes in human primary testicular nonseminomatous germ cell tumors.

G. T. te Meerman, R. Seruca, D. Sleijfer, 1989, Cancer research.

i(12p)-negative testicular germ cell tumors. A different group?

R. Seruca, D. Sleijfer, S. Castedo, 1988, Cancer genetics and cytogenetics.

Dual parameter flow cytometry for deoxyribonucleic acid and intermediate filament proteins of residual mature teratoma. All tumor cells are aneuploid.

L. Looijenga, J. Beck, D. Sleijfer, 1991, Laboratory investigation; a journal of technical methods and pathology.

PLOIDY OF SUBTYPES OF PRIMARY GERM-CELL TUMORS OF THE TESTIS - PATHOGENETIC AND CLINICAL RELEVANCE

D. Sleijfer, C. Cornelisse, J. Oosterhuis, 1989 .

Serum lactate dehydrogenase isoenzyme 1 activity in patients with testicular germ cell tumors correlates with the total number of copies of the short arm of chromosome 12 in the tumor

P. H. Petersen, D. Sleijfer, J. Oosterhuis, 1992, Molecular and General Genetics MGG.

Cytogenetic analysis of the mature and immature teratoma components of a metastatic testicular nonseminomatous germ cell tumor.

D. Sleijfer, J. Oosterhuis, H. Schraffordt koops, 1991, Cancer genetics and cytogenetics.

Treatment of malignant germ cell tumors of the ovary with cisplatin, vinblastine, and bleomycin (PVB).

N. Mulder, J. Bouma, D. Sleijfer, 1984, Cancer treatment reports.

Orchidectomy alone in stage I nonseminomatous testicular germ cell tumors

H. D. de Bruijn, D. Sleijfer, J. Oosterhuis, 1987, Cancer.

Identical chromosome translocations involving the region of the c-myb oncogene in four metastases of a mediastinal teratocarcinoma.

John G. Collard, J. Oosterhuis, D. Sleijfer, 1985, Cancer genetics and cytogenetics.

Evaluation of Pregnancy-Specific β 1 -Glycoprotein in Patients With Non-Seminomatous Testicular Germ Cell Tumors

T. Ockhuizen, D. Sleijfer, A. Suurmeijer, 1983 .

Evaluation of pregnancy-specific beta 1-glycoprotein in patients with non-seminomatous testicular germ cell tumors.

H. D. de Bruijn, T. Ockhuizen, D. Sleijfer, 1982, European journal of cancer & clinical oncology.

The value of AFP and HCG half lives in predicting the efficacy of combination chemotherapy in patients with non-seminomatous germ cell tumors of the testis.

H. D. de Bruijn, T. Ockhuizen, D. Sleijfer, 1981, Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[Results of semi-castration and careful follow-up in patients with stage I non-seminoma testis tumor].

H. D. de Bruijn, D. Sleijfer, J. Oosterhuis, 1986, Nederlands tijdschrift voor geneeskunde.

Non-seminomatous germ cell tumors of the testis. Analysis of AFP and HCG production by primary tumors and retroperitoneal lymph node metastases after PVB combination chemotherapy.

D. Sleijfer, A. Suurmeijer, J. Oosterhuis, 1983, Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Wait-and-see policy in clinical stage I non-seminomatous germ cell tumors of the testis.

H. D. de Bruijn, D. Sleijfer, J. Oosterhuis, 1986, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The pattern of gamma-glutamyl transpeptidase, alkaline phosphatase, serum glutamyl oxalate transaminase and serum glutamyl pyruvate transaminase in patients with disseminated non-seminomatous testicular tumors.

H. D. de Bruijn, T. Ockhuizen, D. Sleijfer, 1984, European journal of cancer & clinical oncology.

Alkaline Phosphatase and Gamma-Glutamyl Transpeptidase and Isoenzyme Pattern of AP in Patients with Stage III Nonseminomatous Testicular Tumors

T. Ockhuizen, D. Sleijfer, H. Koops, 1984 .

Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors.

H. Hoekstra, J. Gietema, W. Sluiter, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

ALTERATIONS IN THYROID HORMONE METABOLISM DURING CHEMOTHERAPY IN PATIENTS WITH TESTICULAR CARCINOMA

D. Sleijfer, P. Willemse, W. Sluiter, 1982, Clinical endocrinology.

Elevation of serum human chorionic gonadotrophin as the only indication for isolated cerebral relapse of a germ cell tumour of the testis.

N. Mulder, D. Sleijfer, H. Schraffordt koops, 1995, European journal of cancer.

Non-seminomatous germ cell tumors of the testis. Analysis of CEA production in primary tumors and in retroperitoneal lymph node metastases after PVB chemotherapy.

T. Ockhuizen, D. Sleijfer, A. Suurmeijer, 1984, European journal of cancer & clinical oncology.

AFP index, a parameter for the detection of brain metastases in non-seminomatous germ cell tumours of the testis.

T. Ockhuizen, D. Sleijfer, H. Schraffordt koops, 1984, European journal of cancer & clinical oncology.

Serumferritin in Patients with Nonseminomatous Testicular Tumors

T. Ockhuizen, D. Sleijfer, A. Suurmeijer, 1984 .

No change in plasma free testosterone ratio and plasma sex hormone-binding globulin concentration during hCG stimulation.

D. Sleijfer, W. Sluiter, H. Doorenbos, 1984, The Journal of clinical endocrinology and metabolism.

A malignant mixed gonadal stromal tumor of the testis with heterologous components and i(12p) in one of its metastases.

R. Seruca, J. Oosterhuis, D. Sleijfer, 1989, Cancer genetics and cytogenetics.

Cytogenetic analysis of the mature teratoma and the choriocarcinoma component of a testicular mixed nonseminomatous germ cell tumor.

D. Sleijfer, J. Oosterhuis, H. Schraffordt koops, 1992, Cancer genetics and cytogenetics.

A residual mature teratoma with a more balanced karyotype than the primary testicular nonseminoma?

R. Seruca, D. Sleijfer, S. Castedo, 1988, Cancer genetics and cytogenetics.

Genetic predisposition to testicular germ-cell tumours.

I. Nolte, H. Hoekstra, R. Sijmons, 2004, The Lancet. Oncology.

Multivariate analysis of prognostic variables in patients with disseminated non-seminomatous testicular cancer: results from an EORTC multi-institutional phase III study.

R. Sylvester, A. V. van Oosterom, S. Kaye, 1987, International journal of andrology.

Thoracotomy as a staging procedure after chemotherapy in the treatment of Stage III nonseminomatous carcinoma of the testis.

J. Oosterhuis, L. Eysman, D. Sleijfer, 1984, The Annals of thoracic surgery.

Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients

D. Sleijfer, P. Willemse, W. Sluiter, 2004, Cancer Chemotherapy and Pharmacology.

Second international congress of hormones and cancer259 Oral high-dose medroxyprogesterone acetate versus tamoxifen in advanced postmenopausal breast cancer and cross-over effect

D. Sleijfer, P. Willemse, T. Tjabbes, 1983 .

A combination of intraarterial chemotherapy, preoperative and postoperative radiotherapy, and surgery as limb‐saving treatment of primarily unresectable high‐grade soft tissue sarcomas of the extremities

W. Molenaar, H. Hoekstra, D. Sleijfer, 1989, Cancer.

The dilemma of the strive for apoptosis in oncology: mind the heart.

E. D. de Vries, J. Gietema, D. V. van Veldhuisen, 2005, Critical reviews in oncology/hematology.

Clinical and genetic aspects of testicular germ cell tumours

H. Hoekstra, J. Hoekstra-Weebers, R. Sijmons, 2008, Hereditary cancer in clinical practice.

Intestinal hemorrhages in patients with a nonseminomatous testicular tumor

J. Plukker, D. Sleijfer, J. Oosterhuis, 1991, Cancer.

CHEMOTHERAPY‐RESISTANT GESTATIONAL TROPHOBLASTIC NEOPLASIA TREATED SUCCESSFULLY WITH CISPLATIN, ETOPOSIDE, AND BLEOMYCIN

J. Bouma, D. Sleijfer, P. Willemse, 1988, Obstetrics and gynecology.

Long-term chemotherapy-related cardiovascular morbidity.

E. D. de Vries, J. Gietema, D. V. van Veldhuisen, 2000, Cancer treatment reviews.

Testicular carcinoma and HLA Class II genes

G. T. te Meerman, I. Nolte, H. Hoekstra, 2002, Cancer.

A phase I pharmacokinetic study of 21-day continuous infusion mitoxantrone.

N. Mulder, E. de Vries, D. Sleijfer, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An oncological view on the blood-testis barrier.

Joost Bart, Elisabeth G E de Vries, Harry J M Groen, 2002, The Lancet. Oncology.

Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer.

D. Sleijfer, W. Sluiter, H. Doorenbos, 1985, Cancer treatment reports.

Spontaneous fracture of the catheter of a totally implantable venous access port: case report of a rare complication.

D. Sleijfer, J. Hoorntje, J. Noyen, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Short-term continuous infusion of mitozantrone for advanced breast cancer

D. Sleijfer, E. Vries, N. Mulder, 1990, The Lancet.

Pharmacokinetics of high dose etoposide (VP 16-213).

N. Mulder, D. Sleijfer, N H Mulder, 1986, European journal of cancer & clinical oncology.

The value of prognostic indices in aplastic anaemia

D. Sleijfer, N. Mulder, H. Nieweg, 1981, Blut.

The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures.

A. Smit, J. Gietema, D. Sleijfer, 2002, Cancer treatment reviews.

Scientific Proceedings Second International Symposium on Cytostatic Drug Resistance

R. Pieters, K. Sikora, W. Siegert, 1991, Journal of Cancer Research and Clinical Oncology.

Risk Factors Determining Chemotherapeutic Toxicity in Patients with Advanced Colorectal Cancer

D. Sleijfer, J. Brouwers, Jacobus R.B.J. Brouwers, 2000, Drug safety.

Prognostic factors in metastatic non-seminomatous germ cell tumours: an interim analysis of the EORTC GU-Group experience.

R. Sylvester, S. Kaye, G. Stoter, 1993, European urology.

Determination of megestrol acetate and cyproterone acetate in serum of patients with advanced breast cancer by high-performance liquid chromatography.

P. Willemse, D. Sleijfer, P. Willemse, 1990, Journal of chromatography.

A phase I study of 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate (D-19466; lobaplatin) administered daily for 5 days.

N. Mulder, E. de Vries, J. Gietema, 1993, British Journal of Cancer.

Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer

D. Sleijfer, Florian Alt, D. Uges, 2000, The Lancet.

Prevalence, changes in and correlates of fatigue in the first year after diagnosis of testicular cancer.

H. Hoekstra, M. Tuinman, J. Hoekstra-Weebers, 2005, Anticancer research.

Chemotherapy with maximally tolerable doses of VP 16-213 and cyclophosphamide followed by autologous bone marrow transplantation for the treatment of relapsed or refractory germ cell tumors.

E. de Vries, D. Sleijfer, N. Mulder, 1988, European journal of cancer & clinical oncology.

Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanoma.

N. Mulder, E. de Vries, D. Sleijfer, 1986, European journal of cancer & clinical oncology.

The educational yield of the international summer school "Oncology for Medical Students".

D. Sleijfer, B. G. Szabó, J. de Vries, 2002, Journal of cancer education : the official journal of the American Association for Cancer Education.

Five years' experience in access surgery for polychemotherapy. An analysis of results in 100 consecutive patients

T. Wobbes, N. Mulder, D. Sleijfer, 1983, Cancer.

Clinical and endocrine effects of cyproterone acetate in postmenopausal patients with advanced breast cancer

N. Mulder, D. Sleijfer, E. Vries, 1988 .

Male sexuality after cancer treatment--needs for information and support: testicular cancer compared to malignant lymphoma.

H. V. D. van de Wiel, H. Hoekstra, D. Sleijfer, 2004, Patient education and counseling.

Detection of anthracycline-induced cardiotoxicity.

E. D. de Vries, J. Gietema, D. V. van Veldhuisen, 1999, Cancer treatment reviews.

Phase II study of subcutaneous interleukin-2 in unselected patients with advanced renal cell cancer on an outpatient basis.

N. Mulder, E. de Vries, J. Buter, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A progress report on the outpatient treatment of patients with advanced renal cell carcinoma using subcutaneous recombinant interleukin-2.

N. Mulder, E. de Vries, J. Buter, 1993, Seminars in Oncology.

Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor

J. Habbema, E. Steyerberg, S. Fosså, 1997, Cancer.

Endoscopic ultrasound-guided fine-needle aspiration in patients with mediastinal abnormalities and previous extrathoracic malignancy.

D. Sleijfer, H. Groen, J. V. van Putten, 2004, European journal of cancer.

Intensive chemotherapy with autologous bone marrow transfusion as primary treatment in women with breast cancer and more than five involved axillary lymph nodes.

N. Mulder, E. de Vries, D. Sleijfer, 1994, European journal of cancer.

High dose etoposide for brain metastases of small cell lung cancer. A phase II study. The EORTC Lung Cancer Cooperative Group.

P. Postmus, J. Mcvie, D. Sleijfer, 1989, British Journal of Cancer.

The metabolic syndrome in cancer survivors.

B. Wolffenbuttel, J. Gietema, S. Oosting, 2010, The Lancet. Oncology.

Phase one study of twice-weekly vindesine.

N. Mulder, E. de Vries, D. Sleijfer, 1985, European journal of cancer & clinical oncology.

Acquired pancytopenia in relatives of patients with aplastic anaemia.

G. Anders, D. Sleijfer, N. Mulder, 2009, Acta medica Scandinavica.

Chromosomal damage in peripheral blood lymphocytes of patients treated for testicular cancer

N. Mulder, D. Sleijfer, H. Schraffordt koops, 2004, Human Genetics.

Cardiotoxicity associated with the use of trastuzumab in breast cancer patients

E. D. de Vries, J. Gietema, D. V. van Veldhuisen, 2007, Expert review of anticancer therapy.

High-dose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancer.

N. Mulder, E. de Vries, D. Sleijfer, 1989, European journal of cancer & clinical oncology.

Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: Phase II study with methotrexate and 5‐fluorouracil

D. Sleijfer, N. Mulder, R. Verschueren, 1991, The British journal of surgery.

Treatment of malignant fibrous histiocytoma of bone. A plea for primary chemotherapy

W. Kamps, G. D. den Heeten, D. Sleijfer, 1985, Cancer.

Symptoms and functional status of patients with disseminated cancer visiting outpatient departments.

R. Otter, B. Meyboom-de Jong, D. Sleijfer, 1998, Journal of pain and symptom management.

Educational needs of general practitioners in palliative care: outcome of a focus group study.

R. Otter, D. Sleijfer, W. J. Meijler, 2005, Journal of cancer education : the official journal of the American Association for Cancer Education.

The Metabolic Syndrome and Disturbances in Hormone Levels in Long-Term Survivors of Disseminated Testicular Cancer

A. Smit, B. Wolffenbuttel, H. Hoekstra, 2005 .

Quality of life of testicular cancer survivors and the relationship with sociodemographics, cancer-related variables, and life events

H. Hoekstra, M. Tuinman, E. Klip, 2006, Supportive Care in Cancer.

Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era

H S Koops, H. Hoekstra, N. Mulder, 2001, Cancer.

Quality of life of survivors of testicular germ cell cancer: a review of the literature

H. Hoekstra, J. Hoekstra-Weebers, D. Sleijfer, 2004, Supportive Care in Cancer.

Quality of life of survivors of testicular germ cell cancer: a review of the literature

D. Sleijfer, J. Fleer, J. Hoekstra-Weebers, 2004, Supportive Care in Cancer.

Combination chemotherapy and radiation for stage IV breast cancer during pregnancy.

D. Sleijfer, P. Willemse, R. van der Sijde, 1990, Gynecologic oncology.

The Role of Meaning in the Prediction of Psychosocial Well-being of Testicular Cancer Survivors

H. Hoekstra, M. Tuinman, D. Sleijfer, 2006, Quality of Life Research.

Erectile dysfunction with chemotherapy

H. Hoekstra, D. Sleijfer, M. F. Driel, 2000, The Lancet.

Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy.

H. V. D. van de Wiel, H. Hoekstra, D. Sleijfer, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Bleomycin and scuba diving: where is the harm?

S. Sleijfer, A. Horwich, S. Kaye, 2007, The Lancet. Oncology.

Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration.

P. Postmus, N. Mulder, H. Sluiter, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The significance of the doctor-patient relationship in coping with cancer.

E. Molleman, D. Sleijfer, A. Vermey, 1984, Social science & medicine.

Alternating cycles of PVB and BEP in the treatment of patients with advanced seminoma.

N. Mulder, E. de Vries, J. Gietema, 1991, European journal of cancer.

The effects of a postgraduate course on opioid-prescribing patterns of general practitioners.

R. Otter, B. Meyboom-de Jong, D. Sleijfer, 2000, Journal of cancer education : the official journal of the American Association for Cancer Education.

Do the eastern and northern parts of The Netherlands differ in testicular cancer?

G. T. te Meerman, D. Sleijfer, M. Schaapveld, 2001, Urology.

Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer.

N. Mulder, E. de Vries, D. Sleijfer, 1993, European journal of cancer.

High-dose etoposide for meningeal carcinomatosis in patients with small cell lung cancer.

P. Postmus, D. Sleijfer, H. H. Berendsen, 1989, European journal of cancer & clinical oncology.

Adrenal steroids as parameters of the bioavailability of MA and MPA.

D. Sleijfer, P. Willemse, T. Tjabbes, 1990, European journal of cancer.

Classification and occurrence of clinically significant drug interactions with irinotecan and oxaliplatin in patients with metastatic colorectal cancer.

W. M. Smit, D. Sleijfer, J. Brouwers, 2005, Clinical therapeutics.

Hepatocellular damage by cyproterone acetate.

N. Mulder, D. Sleijfer, P. Willemse, 1986, European journal of cancer & clinical oncology.

Multicenter phase II study of spiroplatin.

H. Pinedo, D. Sleijfer, J. Vermorken, 1992, Oncology.

Zeniplatin in patients with advanced ovarian cancer, a phase II study with a third generation platinum complex.

N. Mulder, E. de Vries, J. Bouma, 1993, European journal of cancer.

Role of metallothionein in cisplatin sensitivity of germ‐cell tumours

J. Groten, N. Mulder, N. Zwart, 2000, International journal of cancer.

Quality of life and stress response symptoms in long-term and recent spouses of testicular cancer survivors.

H. Hoekstra, M. Tuinman, J. Hoekstra-Weebers, 2004, European journal of cancer.

Quality of life and stress response symptoms in long-term and recent spouses of testicular cancer

H. Hoekstra, J. Hoekstra-Weebers, D. Sleijfer, 2018 .

Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients

H. Groen, R. Hofstra, H. Hoekstra, 2005, Pharmacogenetics and genomics.

Importance of a new tumor market TRA-1-60 in the follow-up of patients with clinical stage I nonseminomatous testicular germ cell tumors

P. Andrews, H. Hoekstra, D. Sleijfer, 1997, Annals of Surgical Oncology.

Long-term Follow-up of Cardiovascular Risk Factors in Patients Given Chemotherapy for Disseminated Nonseminomatous Testicular Cancer

E. D. de Vries, D. Kromhout, N. Mulder, 1992, Annals of Internal Medicine.

Syndrome X in testicular-cancer survivors.

J. Gietema, D. Sleijfer, M. T. Meinardi, 2001, Lancet.

5‐fluorouracil/leucovorin/interferon alpha‐2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration

N. Mulder, D. Sleijfer, H. Sinnige, 1995, Cancer.

Role of an early second-look laparotomy in ovarian cancer.

J. Bouma, D. Sleijfer, P. Willemse, 1989, Gynecologic oncology.

Postmortem diagnosis of testicular cancer

D. Sleijfer, J. Fleer, J. Hoekstra-Weebers, 2002, The Lancet.

EORTC Genito-Urinary Group studies in advanced testicular cancer--past and future.

A. V. van Oosterom, S. Kaye, G. Stoter, 1985, The Australian and New Zealand journal of surgery.

Serotonin metabolism following platinum-based chemotherapy combined with the serotonin type-3 antagonist tropisetron

I. Kema, D. Sleijfer, E. Vries, 2004, Cancer Chemotherapy and Pharmacology.

Review: breast cancer in elderly patients.

D. Sleijfer, P. Willemse, H. de Graaf, 1994, Age and ageing.

Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer.

N. Mulder, E. de Vries, R. Nieweg, 1988, European journal of cancer & clinical oncology.

Carboplatin-based chemotherapy in good prognosis metastatic non seminoma of the testis (NSGCT): An interim report of an MRC/EORTC randomised trial

A. Horwich, D. Sleijfer, 1993 .

The effect of captopril on renal function in patients during the first cis-diamminedichloroplatinum II infusion

A. Donker, N. Mulder, D. Sleijfer, 2004, Cancer Chemotherapy and Pharmacology.

Magnesium and phosphorus

D. Sleijfer, D. Uges, J. Gietema, 1998, The Lancet.

Treatment-associated leukemia following testicular cancer.

P. Hall, B. Kohler, M. Stovall, 2000, Journal of the National Cancer Institute.

Early development of the metabolic syndrome after chemotherapy for testicular cancer.

A. Smit, H. Boezen, A. V. van Roon, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Delay in diagnosis of testicular cancer.

H. Hoekstra, D. Sleijfer, J. Fleer, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Familial testicular cancer in a single-centre population.

H. Hoekstra, W. T. van der Graaf, R. Sijmons, 1999, European journal of cancer.

Bilateral testicular germ cell tumours in patients with initial stage I disease: prevalence and prognosis--a single centre's 30 years' experience.

D. Sleijfer, H. Schraffordt koops, H. J. Hoekstra, 1998, European journal of cancer.

Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma.

N. Mulder, E. de Vries, D. Sleijfer, 1990, British Journal of Cancer.

Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.

E. D. de Vries, N. Mulder, D. Sleijfer, 1994, British Journal of Cancer.

Thoracotomy for postchemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified.

W. Molenaar, H. Hoekstra, A. Nijboer, 1997, Chest.

Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy.

J. Habbema, E. Steyerberg, S. Fosså, 2000, Radiology.

Long-term results of induction- and intensification chemotherapy supported with autologous bone marrow reinfusion in patients with disseminated or T4 breast cancer.

N. Mulder, E. de Vries, D. Sleijfer, 1995, Anticancer research.

Cardiotoxicity after anticancer treatment

D. Sleijfer, D. V. Veldhuisen, P. Perik, 2005 .

Neuropsychiatric symptoms during treatment with interleukin-2

J. Buter, D. Sleijfer, E. Vries, 1993, The Lancet.

The therapeutic challenge of a nonresectable solitary fibrous tumor in a hypoglycemic patient

T. Wiggers, P. Nieboer, P. L. Jager, 2006, International Journal of Clinical Oncology.

5‐fluorouracil/leucovorin/interferon alpha‐2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration

N. Mulder, J. Buter, D. Sleijfer, 1995, Cancer.

Quality of life and stress response symptoms in long-term and recent spouses of testicular cancer survivors

M. Tuinman, J. Hoekstra-Weebers, D. Sleijfer, 2004 .

Clinical Investigations: CancerThoracotomy for Postchemotherapy Resection of Pulmonary Residual Tumor Mass in Patients With Nonseminomatous Testicular Germ Cell Tumors: Aggressive Surgical Resection Is Justified

W. Molenaar, H. Hoekstra, D. Sleijfer, 1997 .

Selective Decontamination of the Digestive Tract as a Method of Infection Prevention in Granulocytopenic Patients; A Follow-Up Study in 102 Patients

D. Sleijfer, N. Mulder, D. Waaij, 1984 .

Oral high‐dose medroxyprogesterone acetate versus tamoxifen: A randomized crossover trial in postmenopausal patients with advanced breast cancer

D. Sleijfer, T. Tjabbes, H. van Veelen, 1986, Cancer.

Early development of the metabolic syndrome after chemotherapy for testicular cancer.

A. Smit, H. Boezen, B. Wolffenbuttel, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer.

A. V. van Roon, M. P. van den Berg, H. Hoekstra, 2004, European journal of cancer.